To mitigate the risks associated with inhaled nanoparticles, extensive toxicological studies are conducted to understand their interactions with biological systems. Regulatory agencies, such as the FDA and EPA, have established guidelines and safety standards for the use of nanoparticles in medical and industrial applications. Additionally, researchers are developing biocompatible and biodegradable nanoparticles to reduce potential risks.
